Skip to main content

Day: June 7, 2021

Translate Bio Achieves Manufacturing Milestone Related to Influenza mRNA Vaccine Program

— $50 million milestone payment to be received this month for successful manufacturing, release, and delivery of clinical drug product to support influenza mRNA vaccine clinical trial anticipated to begin in the coming weeks — LEXINGTON, Mass., June 07, 2021 (GLOBE NEWSWIRE) —  Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative medicines to treat or prevent debilitating or life-threatening diseases, today announced it has achieved a manufacturing milestone under the collaboration with Sanofi Pasteur related to its influenza mRNA vaccine program. Translate Bio will receive a $50 million payment from Sanofi Pasteur for the successful manufacture, release, and delivery of clinical drug product to supply Sanofi Pasteur’s Phase 1 influenza...

Continue reading

Positive Preliminary Results from Delcath Systems’ FOCUS Trial Presented at the 2021 ASCO Annual Meeting

As Previously Disclosed, the Prespecified Primary Endpoint, Objective Response Rate, Has Been Met by Exceeding the 95% CI Lower Bound Threshold for Success Newly Disclosed Patient Level Data Demonstrates a 44% Best Overall Response for the HEPZATO Arm Versus 17% for the Best Alternative Care Arm Company Q&A Webinar Today at 8:30am ET NEW YORK, June 07, 2021 (GLOBE NEWSWIRE) — Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today announced an oral presentation of positive preliminary efficacy results from its FOCUS Phase III trial of HEPZATO™ KIT (melphalan hydrochloride for injection/hepatic delivery system) in patients with liver dominant metastatic ocular melanoma (mOM) at the American Society of Clinical Oncology (ASCO) Annual...

Continue reading

Digihost Announces Launch of the DigiGreen Initiative

TORONTO, June 07, 2021 (GLOBE NEWSWIRE) — Digihost Technology Inc. (“Digihost” or the “Company”) (TSXV: DGHI; OTCQB: HSSHF) is pleased to announce the launch of its new DigiGreen Initiative, an industry leading plan to reduce the Company’s already low carbon footprint. In addition to achieving technological and economic excellence, since inception, the Company has focused on being a good corporate citizen and operating its business in an environmentally and socially responsible way. As part of this mandate, the Company located its cryptocurrency mining farm in Upstate New York to take advantage of the low carbon emission energy profile of that area. The Company believes that more can be done to further reduce its carbon footprint, while maintaining its industry leading efficient cryptocurrency mining operations, and is therefore...

Continue reading

One Medical Announces Agreement to Acquire Iora Health

One Medical expands member-based, technology-powered primary care model to every stage of life, and extends into full-risk Medicare reimbursement models Positions One Medical to deliver better health, better care, and lower costs across a combined 28 markets and beyond SAN FRANCISCO, June 07, 2021 (GLOBE NEWSWIRE) — 1Life Healthcare, Inc. (One Medical) (Nasdaq: ONEM), a leading human-centered and technology-powered primary care organization, today announced it has entered into a definitive agreement to acquire Iora Health, a human-centric, value-based primary care group with built-for-purpose technology focused on serving Medicare populations, in an all-stock transaction valued at approximately $2.1 billion. “We are delighted to announce plans to combine with Iora Health, a technology-powered primary care leader delivering outstanding...

Continue reading

FDA confirms NDA for Oleogel-S10 will not require an Advisory Committee Meeting

FDA confirms NDA for Oleogel-S10 will not require an Advisory Committee Meeting DUBLIN, Ireland, and Boston MA, June 7, 2021, Amryt (Nasdaq: AMYT, AIM: AMYT), a global, commercial-stage biopharmaceutical company dedicated to acquiring, developing and commercializing novel treatments for rare diseases, today announces that the U.S. Food and Drug Administration (“FDA”) has confirmed that Amryt’s New Drug Application (“NDA”) for Oleogel-S10 for the treatment of Epidermolysis Bullosa (“EB”) will not require an Advisory Committee meeting.   Oleogel-S10 is a potential treatment for the cutaneous manifestations of Junctional and Dystrophic EB, a rare and distressing genetic skin disorder affecting young children and adults for which there is currently no approved treatment. About AmrytAmryt is a global commercial-stage biopharmaceutical company...

Continue reading

GURU Organic Energy to Report Second Quarter 2021 Results

MONTREAL, June 07, 2021 (GLOBE NEWSWIRE) — GURU Organic Energy Corp. (TSX: GURU) (“GURU” or the “Company”), Canada’s leading organic energy drink brand, will report its financial results for the second quarter ended April 30, 2021, after market close on Monday, June 14, 2021. Management will hold a conference call to discuss its financial results the same day at 5:30 p.m. ET. The conference call will include a Q&A period open exclusively to financial analysts who are invited to participate by using the dial-in number provided below. Other interested parties are invited to participate in the call on a listen-only basis and are encouraged to do so via live audio webcast, which will be available on GURU’s website. Second quarter 2021 conference call details:Monday, June 14, 2021, at 5:30 p.m. ET Via webcast at https://edge.media-server.com/mmc/p/kq6sd3b4 Via...

Continue reading

Class 1 Nickel and Technologies Closes $4 Million Private Placement of Flow-Through Units

TORONTO, June 07, 2021 (GLOBE NEWSWIRE) — Class 1 Nickel and Technologies Ltd. (CSE: NICO) (OTCQB: NICLF) (“Class 1 Nickel” or the “Company”) is pleased to announce that it has closed its previously announced brokered private placement (the “Offering”) led by Echelon Capital Markets (“Echelon”), as sole agent and bookrunner. Pursuant to the Offering, the Company issued 3,030,000 units to residents of Quebec at a price of $0.65 per Unit and 3,403,334 units to residents in Canada at a price of $0.60 per Unit, resulting in a total of 6,433,334 units (each a “Unit”) issued for total gross proceeds of $4,011,500. Each Unit is comprised of one common share in the capital of the Company (a “Unit Share”), and one common share purchase warrant (a “Warrant”). Each Warrant is exercisable to purchase one common share in the capital of the...

Continue reading

Concrete Pumping Holdings Reports Strong Preliminary Second Quarter Fiscal Year 2021 Results and Reschedules Second Quarter Fiscal Year 2021 Call to June 14, 2021

– Preliminary Q2 Results Show Strong Continued Growth and Market Resilience– Reschedule Being Driven by Finalization of Accounting for SPAC Warrants DENVER, June 07, 2021 (GLOBE NEWSWIRE) — Concrete Pumping Holdings, Inc. (Nasdaq: BBCP) (the “Company” or “CPH”), a leading provider of concrete pumping and waste management services in the U.S. and U.K., is providing preliminary financial results for its second quarter of fiscal year 2021 ended April 30, 2021 and has rescheduled its second quarter fiscal 2021 earnings call to June 14, 2021. Preliminary Second Quarter Fiscal Year 2021 Summary vs. Second Quarter of Fiscal Year 2020 (where applicable)Revenue increased 4% to $76.9 million compared to $74.0 million. Gross margin increased 30 basis points to 43.3% compared to 43.0%. Adjusted EBITDA1 increased 7% to $25.0 million...

Continue reading

REPEAT: Clean Power Announces Name Change to PowerTap Hydrogen Capital Corp.

VANCOUVER, British Columbia and IRVINE, Calif., June 07, 2021 (GLOBE NEWSWIRE) — Clean Power Capital Corp. (NEO: MOVE)(FWB: 2K6)(OTC: MOTNF) (“Clean Power” or the “Company” or “MOVE”) is pleased to announce that the Company will change its name to “PowerTap Hydrogen Capital Corp.”, effective June 14, 2021, in conjunction with its transition to a single purpose hydrogen fueling technology company, previously announced on June 1, 2021. The Company will continue to trade under the stock symbol “MOVE” on the NEO Exchange (“NEO”).  This name change emphasizes the Company’s transition to a single purpose company from an investment issuer, redeploying its assets and resources to be a single purpose hydrogen fueling technology company. The name change and the transition to a single...

Continue reading

Red White & Bloom Closes US$44.5 Million in Financing and Retires US$7.7 Million in Debt

-Transactions provide a net cash infusion of US$36.8 Million--Fully funds initial budget for Florida expansion--Provides working capital to support Michigan branding and expansion strategy- TORONTO, June 07, 2021 (GLOBE NEWSWIRE) — Red White & Bloom Brands Inc. (CSE: RWB and OTC: RWBYF) (“RWB” or the “Company”) is pleased to announce the completion of certain financing transactions that provide for approximately US$36.8 of new cash and the retirement of US$7.7M of debt. “As evidenced by today’s announcement, we continue to demonstrate our ability to access the needed expansion and working capital, in the least dilutive possible manner to our shareholders, to execute on our strategy. With the previously announced pre-qualification in the State of Michigan and this cash injection, we will now move aggressively towards taking...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.